Phoenix Nuclear was formed to commercialize a high-output particle source capable of creating high energy protons and neutrons. These particles have applications in a wide range of emerging markets, including medical isotope production, neutron therapy, and nuclear weapons detection. PNL has a strong revenue stream from its first successful application, but low profits. We are seeking financing to break into additional markets.